Paul H Frankel Selected Research

64Cu-DOTA-trastuzumab

1/2022	Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study.
1/2018	Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul H Frankel Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 04/2012
9	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2014
3	Thrombocytopenia (Thrombopenia) 10/2021 - 08/2017
3	Triple Negative Breast Neoplasms 01/2021 - 01/2020
2	Neutropenia 10/2021 - 01/2021
1	Fatigue 01/2022
1	Fever (Fevers) 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2021
1	Carcinoma (Carcinomatosis) 10/2021
1	Residual Neoplasm 01/2021
1	Cytopenia 02/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Diarrhea 01/2019
1	Carcinogenesis 01/2019
1	Nausea 08/2017
1	Dehydration (Water Stress) 08/2017
1	Ovarian Neoplasms (Ovarian Cancer) 03/2016
1	Venous Thromboembolism 07/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2014
1	Thrombophilia 07/2014
1	Prostatic Neoplasms (Prostate Cancer) 03/2014
1	Melanoma (Melanoma, Malignant) 04/2012
1	Anemia 04/2012
1	Disease Progression 03/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2012
1	Multiple Myeloma 03/2012
1	Crohn Disease (Crohn's Disease) 04/2005
1	Inflammation (Inflammations) 04/2005

Drug/Important Bio-Agent (IBA)

3	Hormones (Hormone)IBA 06/2022 - 07/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2014
3	human ERBB2 proteinIBA 01/2021 - 01/2014
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2014
2	64Cu-DOTA-trastuzumabIBA 01/2022 - 01/2018
2	Gemcitabine FDA Link 10/2021 - 02/2020
2	PlatinumIBA 01/2021 - 03/2015
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 08/2017
2	SeleniumIBA 03/2014 - 04/2005
1	Cyclin-Dependent Kinase 4IBA 06/2022
1	Ado-Trastuzumab EmtansineIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	COH04S1 COVID-19 vaccineIBA 01/2022
1	Single-Stranded DNA (DNA, Single Stranded)IBA 10/2021
1	berzosertibIBA 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	pembrolizumabIBA 01/2021
1	palbociclibIBA 01/2021
1	Letrozole (Femara)FDA LinkGeneric 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	ostarineIBA 01/2021
1	EnzymesIBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	Carcinoembryonic AntigenIBA 02/2020
1	Indium-111IBA 02/2020
1	Yttrium-90IBA 02/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	IntegrinsIBA 10/2019
1	cabozantinibIBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Amylases FDA Link 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Poly Adenosine Diphosphate RiboseIBA 08/2017
1	veliparibIBA 08/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2017
1	Monoclonal AntibodiesIBA 03/2016
1	VaccinesIBA 03/2016
1	baicaleinIBA 03/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 03/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2014
1	Blood Coagulation Factors (Coagulation Factor)IBA 07/2014
1	AntibodiesIBA 03/2014
1	CreatinineIBA 04/2012
1	7-hydroxystaurosporine (UCN 01)IBA 04/2012
1	Bortezomib (Velcade)FDA Link 03/2012
1	Thalidomide (Thalomid)FDA Link 03/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2012
1	PeroxidasesIBA 04/2005
1	Glutathione (Reduced Glutathione)IBA 04/2005
1	Glutathione PeroxidaseIBA 04/2005

Therapy/Procedure

7	Therapeutics 10/2021 - 03/2012
3	Drug Therapy (Chemotherapy) 03/2016 - 07/2014
2	Neoadjuvant Therapy 01/2021 - 09/2014
1	Time-to-Treatment 01/2022
1	Drug Tapering 10/2021
1	Immunotherapy 03/2016
1	Chemoprevention 03/2015
1	Catheters 07/2014
1	Stem Cell Transplantation 03/2012
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2012